Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAP3K5 | Q99683 | 2/20 | 0.55 |
| ▸ | BRAF | P15056 | 14/20 | 0.42 |
| ▸ | MAP4K1 | Q92918 | 1/20 | 0.41 |
| ▸ | PTK6 | Q13882 | 1/20 | 0.40 |
| ▸ | ROCK2 | O75116 | 2/20 | 0.40 |
| ▸ | PIM1 | P11309 | 1/20 | 0.39 |
| ▸ | GSK3B | P49841 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30512123 | 0.92 | MAP4K1 (0.49) | MAP3K5BRAFMAP4K1PTK6ROCK2 | |
| SCHEMBL25882177 | 0.92 | MAP4K1 (0.49) | MAP3K5BRAFMAP4K1PTK6ROCK2 | |
| SCHEMBL25880620 | 0.81 | MAP3K5 (0.42) | MAP3K5BRAFMAP4K1PTK6ROCK2 | |
| SCHEMBL25882124 | 0.79 | MAP3K5 (0.63) | MAP3K5BRAFMAP4K1ROCK2 | |
| SCHEMBL25880776 | 0.78 | MAP3K5 (0.72) | MAP3K5BRAFROCK2 | |
| SCHEMBL30512125 | 0.72 | MAP4K1 (0.59) | MAP3K5BRAFMAP4K1ROCK2 | |
| SCHEMBL30512127 | 0.71 | MAP3K5 (0.53) | MAP3K5BRAFMAP4K1ROCK2 | |
| SCHEMBL25881300 | 0.71 | MAP3K5 (0.53) | MAP3K5BRAFMAP4K1ROCK2 | |
| SCHEMBL25882326 | 0.71 | MAP3K5 (0.60) | MAP3K5BRAFMAP4K1ROCK2GSK3B | |
| SCHEMBL30512131 | 0.70 | MAP3K5 (0.61) | MAP3K5BRAFMAP4K1ROCK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023138412-A1 | FUSED PYRIMIDIN-2-AMINE COMPOUNDS AS CDK20 INHIBITORS | INSILICO MEDICINE IP LIMITED (CN) | 2023-07-27 | — | — | WO | disclosed |
| WO-2023138412-A1 | FUSED PYRIMIDIN-2-AMINE COMPOUNDS AS CDK20 INHIBITORS | INSILICO MEDICINE IP LIMITED (CN) | 2023-07-27 | — | — | WO | disclosed |